Craneware plc 14.7% potential upside indicated by Berenberg Bank

Craneware plc with ticker (LON:CRW) now has a potential upside of 14.7% according to Berenberg Bank.

CRW.L

Berenberg Bank set a target price of 2,700 GBX for the company, which when compared to the Craneware plc share price of 2,353 GBX at opening today (13/08/2024) indicates a potential upside of 14.7%. Trading has ranged between 1,325 (52 week low) and 2,509 (52 week high) with an average of 53,569 shares exchanging hands daily. The market capitalisation at the time of writing is £829,994,150.

Craneware plc is a United Kingdom company that is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company is engaged in automated value cycle solutions, including 340B management, collaborates with United States healthcare providers to plan, execute, and monitor operational and financial performance, so they can deliver quality care to their communities. The Company combines revenue integrity, cost management, 340B performance, and decision enablement into a single, software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others.